Medicalook
Medicalook

Benzatropina

http://www.medicalook.com
Benzatropina

Benzatropina review





Benzatropina is an anticholinergic medication used for treating Parkinsons disease and related conditions such as parkinsonism, dystonia, and akathasia. Its effects have been shown to have an effective and significant therapeutic value in the management of the symptoms of parkinsonism. It counteracts the effects of the neurotransmitter acetylcholine and balances the levels of acetylcholine and dopamine in the body, which may help reduce the symptoms of Parkinson's disease in its early stages. It can also be used to treat movement disorders resulting from the use of other antipsychotic medication. Aside from its anticholinergic effect, doctors have also observed an antihistaminic activity approaching that of pyrilamine maleate.

It is available as a tablet in 0.5 mg, 1 mg or 2 mg dosages and is available as brand names such a Cogentin.

Usually this medication is prescribed for most forms of parkinsonism and movement disorders resulting from the use of antipsychotic medicaments, with the exception of tardive dyskenesia. It can also be a useful part of Parkinson's treatment where it helps reduce symptoms of tremors rather than the stiffness of motion. Sufferers of dystonia also benefit from Benzatropina since it can relax the sudden contortions of the limbs and torso that these patients can suffer.

Benzatropina is typically administered using the lowest dosage possible, with the doctor monitoring the patient's condition as the dosage is increased by 0.5mg every 5 to 6 days, up to a maximum dosage of 6 mg. The reason is to find the optimal dosage for the patient using the least amount of medicine possible.

Usually the doctor will instruct the patient to take the medicine 2 to 4 times each day along with meals and before bedtime or as a single dosage taken at bedtime. The doctor may modify dosage as he sees fit to the patient's condition.

Benzatropina should be taken at least an hour before taking antacids containing calcium, magnesium or aluminum. Also allow one to two hours before and after taking Benzatropina when taking adsorbent diarrhea medication containing pectin, kaolin or attapulgite as this may affect absorption of Benzatropina. If you are taking ketoconazole, do not take Benzatropina until two hours after the ketoconazole dosage as it may affect the absorption of the keotconazole.

If Benzatropina is being taken to counteract side effects caused by another antipsychotic medication, your doctor may tell you to take it only as necessary. The doctor may also alter the dosage of the other medicaments you are taking. Follow the doctor's instructions carefully.

In rare cases, an addiction may arise from the use of this medication. Do not extend your treatment or increase your dosage. Proper stopping of treatment will be essential, but in certain cases an abrupt discontinuing of dosage may aggravate certain symptoms so the doctor may design an increasingly lowered dosage until you can safely stop taking the medication.

Dizziness, costiveness, nausea, drowsiness, blurred vision or a dry mouth may occur as a side effect of Benzatropina use. The side effects may reduce as you get used to the medication, but if any of these effects worsen or persist, consult your doctor.

Inform your doctor of any occurrence of high pyrexias, severe stomach pain, any difficulty in passing urine, weakness or a decrease in sexual ability. However, if you feel chest pains, dizziness which results in fainting, mood swings or mental disturbances, irregular heartbeats or symptoms of extreme allergic reactions such as rashes, pyrexia or inflammation, seek medical attention immediately.

Inform your doctor of any existing medical conditions, including heart disease, glaucoma, gastrointestinal disorders such as ulcers and blockage, liver disease, other mental and movement disorders, high blood pressure, or disorders causing difficulty in micturition.

Be aware of the drowsiness Benzatropina may cause, and avoid spending time in poorly ventilated and hot areas as some users may experience an increase in body temperature.

Benzatropina has the following structural formula:

Chemical structure of benzatropina


• Molecular formula of benzatropina is C21H25NO
• Chemical IUPAC Name is 3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane
• Molecular weight is 307.429 g/mol
Benzatropina available : 0,5mg tablets, 1mg tablets and 2mg tablets

Generic name: Benztropine

Brand name(s): Akitan, Benzatropine, Benzatropinum, Benztropine mesylate, Benztropinum, Cobrentin, Cogentin, Cogentine, Cogentinol

  Your Benzatropina review